Effect of Lutetium-177 Dota Octreotate Peptide Receptor Radionuclide Therapy in Patients With Advanced Neuroendocrine Tumors and Carcinoid Syndrome Refractory to Somatostatin Analogues

被引：0
|
作者：
Koffas, Apostolos
Popat, Rickin
Demetriou, George
Quigley, Ann-Marie
Navalkissoor, Shaunak
Caplin, Martyn
Toumpanakis, Christos
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)30774-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1059
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [41] Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy
    De Silva, Madhawa K.
    Chan, David L. H.
    Bernard, Elizabeth J.
    Conner, Alice J.
    Mascall, Sophie L.
    Bailey, Dale L.
    Roach, Paul J.
    Clarke, Stephen J.
    Diakos, Connie I.
    Pavlakis, Nick
    Schembri, Geoff
    PANCREAS, 2024, 53 (07) : e560 - e565
  • [42] Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas
    Iliuta, Ioan-Andrei
    Beauregard, Jean-Mathieu
    Couture, Felix
    Douville, Pierre
    Mac-Way, Fabrice
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (09) : E448 - E450
  • [43] PHASE 1 STUDY OF EVEROLIMUS COMBINED WITH LUTETIUM-177 OCTREOTATE RADIOPEPTIDE THERAPY OF ADVANCED LOW-GRADE NEUROENDOCRINE TUMOURS
    Claringbold, P.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 379 - 379
  • [44] [177Lu-DOTA0, Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy
    de Jong, M
    Breeman, WAP
    Bernard, BF
    Bakker, WH
    Schaar, M
    van Gameren, A
    Bugaj, JE
    Erion, J
    Schmidt, M
    Srinivasan, A
    Krenning, EP
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (05) : 628 - 633
  • [45] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Ezziddin, Samer
    Khalaf, Feras
    Vanezi, Maria
    Haslerud, Torjan
    Mayer, Karin
    Al Zreiqat, Abdullah
    Willinek, Winfried
    Biersack, Hans-Juergen
    Sabet, Amir
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 925 - 933
  • [46] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Samer Ezziddin
    Feras Khalaf
    Maria Vanezi
    Torjan Haslerud
    Karin Mayer
    Abdullah Al Zreiqat
    Winfried Willinek
    Hans-Jürgen Biersack
    Amir Sabet
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 925 - 933
  • [47] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Del Prete, Michela
    Buteau, Francois-Alexandre
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1490 - 1500
  • [48] Survival Analysis of Combined Therapy with 177Lu-Octreotate and Somatostatin Analogues in Advanced Metastatic Neuroendocrine Tumours
    Yordanova, A.
    Wicharz, M.
    Gonzalez-Carmona, M.
    Strassburg, C.
    Mayer, K.
    Brossart, P.
    Essler, M.
    Ahmadzadehfar, H.
    NEUROENDOCRINOLOGY, 2017, 105 : 258 - 258
  • [49] Safety and efficacy of peptide receptor radionuclide therapy with 177 Lu-DOTA 0-Tyr 3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
    Kobayashi, N.
    Takano, S.
    Ito, K.
    Sugiura, M.
    Ogawa, M.
    Takeda, Y.
    Okubo, N.
    Suzuki, A.
    Tokuhisa, M.
    Kaneta, T.
    Utsunomiya, D.
    Hata, M.
    Inoue, T.
    Hosono, M.
    Kinuya, S.
    Ichikawa, Y.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 149 - 149
  • [50] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Michela Del Prete
    François-Alexandre Buteau
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1490 - 1500
12345